60 related articles for article (PubMed ID: 15057442)
1. Does the use of paclitaxel or rapamycin-eluting stent decrease further need for coronary-artery bypass grafting when compared with bare-metal stent?
Lemos HP; Atallah AN
Sao Paulo Med J; 2007 Jul; 125(4):242-5. PubMed ID: 17992397
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness of new generation drug-eluting stents in ostial right coronary artery lesions.
De Rosa M; Santulli G
Int J Cardiol; 2018 Mar; 254():84-86. PubMed ID: 29407134
[No Abstract] [Full Text] [Related]
3. Drug-Eluting Stents and Balloons-Materials, Structure Designs, and Coating Techniques: A Review.
Rykowska I; Nowak I; Nowak R
Molecules; 2020 Oct; 25(20):. PubMed ID: 33050663
[TBL] [Abstract][Full Text] [Related]
4. Cardiovascular stents: overview, evolution, and next generation.
Borhani S; Hassanajili S; Ahmadi Tafti SH; Rabbani S
Prog Biomater; 2018 Sep; 7(3):175-205. PubMed ID: 30203125
[TBL] [Abstract][Full Text] [Related]
5. [Acute coronary syndrome - a challenge for the cooperation between outpatient and inpatient care].
Dörr R
Herz; 2008 Sep; 33(6):395-401. PubMed ID: 19156374
[TBL] [Abstract][Full Text] [Related]
6. [Safety and current indications during "real life" use of sirolimus-eluting coronary stents in Germany. Results from the prospective multicenter German Cypher Registry].
Zahn R; Hamm CW; Zeymer U; Schneider S; Nienaber CA; Richardt G; Kelm M; Levenson B; Bonzel T; Tebbe U; Schöbel WA; Sabin G; Senges J;
Herz; 2004 Mar; 29(2):181-6. PubMed ID: 15057439
[TBL] [Abstract][Full Text] [Related]
7. Drug-eluting stents for in-stent restenosis and acute myocardial infarction: present data from nonrandomized studies.
Schofer J; Bode C; Silber S
Herz; 2004 Mar; 29(2):195-200. PubMed ID: 15057441
[TBL] [Abstract][Full Text] [Related]
8. Cost-effectiveness of drug-eluting stents: if only all things were equal.
Chew DP
Med J Aust; 2005 Apr; 182(8):376-7. PubMed ID: 15850431
[TBL] [Abstract][Full Text] [Related]
9. Rapamycin analogs for stent-based local drug delivery. Everolimus- and tacrolimus-eluting stents.
Grube E; Buellesfeld L
Herz; 2004 Mar; 29(2):162-6. PubMed ID: 15054588
[TBL] [Abstract][Full Text] [Related]
10. [Do drug-eluting stents influence the spectrum of coronary artery bypass surgery?].
Matschke K; Tugtekin SM; Kappert U; Jung F; Park JW; Knaut M
Herz; 2004 Mar; 29(2):201-7. PubMed ID: 15057442
[TBL] [Abstract][Full Text] [Related]
11. Classification and current treatment options of in-stent restenosis. Present status and future perspectives.
Ong AT; Aoki J; McFadden EP; Serruys PW
Herz; 2004 Mar; 29(2):187-94. PubMed ID: 15057440
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
